4
Tetrahedron
777 (w), 731 (w), 702 (w). HRMS (m/z) [M+H]+ calcd for C11H18N,
reaction stream was passed through a short segment of stainless
ACCEPTED MANUSCRIPT
164.1434; found, 164.1435.
steel tubing to enable the reaction to cool and then exited the
system by passage through the back pressure regulator (Note:
PFA fittings should not be used at the exit of the reactor as they
will deform due to the high temperature of the reaction stream
and cause leaks in the system. Stainless steel connectors and
tubing (12”) were used in our system.). After the flow system
was equilibrated for 18 minutes, the product stream was collected
for 5 min (2.77 mmol of aniline). The crude mixture was
dissolved in ethyl acetate and washed with brine. The combined
organic layers were dried over magnesium sulfate, filtered, and
concentrated under reduced pressure. The residue was purified by
column chromatography (Biotage 25 g Ultra-sil, 3–15% ethyl
4.2.5. N-methyl-[1,1'-biphenyl]-4-amine (3e)
323 mg (64%); yellow solid; H NMR (400 MHz, CDCl3) δ 7.55
(d, J = 7.0 Hz, 2H), 7.49 (d, J = 8.4 Hz, 2H), 7.40 (t, J = 7.6 Hz, 2H),
7.27 (t, J = 7.4 Hz, 1H), 6.79 (d, J = 7.6 Hz, 2H), 3.42 (br s, 1H),
2.91 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 147.5, 141.1, 131.4,
128.6, 128.0, 126.4, 126.2, 113.6, 31.4. The 1H and 13C NMR spectra
are in agreement with those reported in the literature.18
1
4.2.6. 4-iodo-N-methylaniline (3f)
490 mg (76%); yellow oil; H NMR (400 MHz, CDCl3) δ 7.50 –
1
7.40 (m, 2H), 6.47 – 6.44 (m, 2H), 3.37 (br s, 1H), 2.81 (s, 3H). 13C
NMR (101 MHz, CDCl3) δ 137.8, 115.2, 31.0. IR (neat, cm-1) 3418
(m), 3182 (w), 2984 (w), 2922 (w), 2879 (m), 2811 (m), 2571 (w),
2384 (w), 2295 (w), 2118 (w), 1869 (w), 1590 (w), 1494 (s), 1430
(w), 1389 (m), 1314 (s), 1293 (m), 1257 (s), 1180 (s), 1154 (m),
1111 (w), 1067 (w), 1051 (m), 993 (m), 807 (s), 751 (m), 692 (m).
HRMS (m/z) [M+H]+ calcd for C7H9IN, 233.9774; found, 233.9782.
4.2.7. 3-bromo-N-methylaniline (3g)
1
490 mg (96%); yellow oil; H NMR (400 MHz, CDCl3) δ 7.03 (t,
J = 8.0 Hz, 1H), 6.85 – 6.82 (m, 1H), 6.77 (t, J = 2.0 Hz, 1H), 6.57 –
6.54 (m, 1H), 4.07 (br s, 1H), 2.82 (s, 3H). 13C NMR (101 MHz,
CDCl3) δ 150.0, 130.4, 123.3, 120.4, 115.2, 111.6, 30.8. The 1H and
13C NMR spectra are in agreement with those reported in the
literature.17
4.2.8. 3-methoxy-N-methylaniline (3h)
1
183 mg (48%); yellow oil; H NMR (400 MHz, CDCl3) δ 7.11 (t,
J = 8.1 Hz, 1H), 6.34 – 6.28 (m, 2H), 6.23 (q, J = 2.3 Hz, 1H), 4.07
(br s, 1H), 3.79 (s, 3H), 2.84 (s, 3H). 13C NMR (101 MHz, CDCl3) δ
1
160.8, 149.9, 130.0, 106.2, 103.2, 99.0, 55.1, 31.2. The H NMR
spectra is in agreement with that reported in the literature. 19
4.2.9. 2-(methylamino)benzonitrile (3i)
1
70 mg (19%); yellow solid; H NMR (400 MHz, CDCl3) δ 7.42
(dt, J = 7.5, 1.9 Hz, 2H), 6.76 (td, J = 7.2, 6.7 Hz, 2H), 4.17 (br s,
acetate in hexanes) to afford the desired product.
1H), 2.95 (d, J = 2.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 151.0
1
134.3, 132.8, 117.6, 116.0, 109.7, 95.2, 30.6. The H and 13C NMR
spectra are in agreement with those reported in the literature.17
Fig. 2. Photographs of E-series flow platform.
4.2.1. 4-chloro-N-methylaniline (3a)
4.2.10. N-methyl-2-(1H-pyrrol-1-yl)aniline (3j)
119 mg (25%); clear oil; 1H NMR (400 MHz, CDCl3) δ 7.30 (td, J
= 7.8, 1.6 Hz, 1H), 7.17 (dd, J = 7.6, 1.6 Hz, 1H), 6.92 – 6.77 (m,
4H), 6.35 (t, J = 2.1 Hz, 2H), 5.20 (br s, 1H), 2.77 (s, 3H). 13C NMR
(101 MHz, CDCl3) δ 144.5, 128.9, 127.3, 126.9, 121.9, 116.5, 110.8,
109.3, 30.3. IR (neat, cm-1) 3422 (m), 2918 (m), 2880 (m), 2817 (m),
1741 (w), 1606 (m), 1586 (m), 1516 (s), 1484 (m), 1317 (s), 1291
(m), 1265 (w), 1247 (w), 1168 (m), 1117 (w), 1094 (m), 1065 (m),
1038 (w), 1013 (m), 923 (m), 842 (w), 801 (w), 722 (s). HRMS
(m/z) [M+H]+ calcd for C11H13N2, 173.1073; found, 173.1069.
1
307 mg (79%); yellow oil; H NMR (400 MHz, CDCl3) δ 7.20 –
7.07 (m, 2H), 6.62 – 6.50 (m, 2H), 3.85 (br s, 1H), 2.82 (s, 3H). 13C
NMR (101 MHz, CDCl3) δ 147.6, 129.0, 122.0, 113.6, 30.9. 1H
NMR spectra is in agreement with that reported in the literature.16
4.2.2. N-methyl-4-(trifluoromethyl)aniline (3b)
1
359 mg (74%); clear oil; H NMR (400 MHz, CDCl3) δ 7.43 (d, J
= 8.4 Hz, 2H), 6.68 (d, J = 8.0 Hz, 2H), 4.36 (br s, 1H), 2.88 (s, 3H).
13C NMR (101 MHz, CDCl3) δ 150.7, 126.6 (q, J = 3.9 Hz), 126.2,
4.2.11. (2-(methylamino)phenyl)(phenyl)methanone
(3k)
1
123.5, 112.2, 30.8. The H NMR spectra is in agreement with that
215 mg (37%); yellow solid; 1H NMR (400 MHz, CDCl3) δ 7.65 –
7.57 (m, 2H), 7.55 – 7.48 (m, 2H), 7.48 – 7.40 (m, 3H), 6.91 (d, J =
8.4 Hz, 1H), 6.64 (t, J = 7.6 Hz, 1H), 2.99 (s, 3H). 13C NMR (101
MHz, CDCl3) δ 199.1, 151.2, 140.1, 135.3, 135.0, 130.9, 129.0,
128.7, 128.1, 118.4, 115.2, 112.6, 30.4. The 1H and 13C NMR spectra
are in agreement with those reported in the literature. 20
reported in the literature.16
4.2.3. N,4-dimethylaniline (3c)
168 mg (50%); clear oil; 1H NMR (400 MHz, CDCl3) δ 7.03 (d, J
= 7.9 Hz, 2H), 6.56 (d, J = 8.2 Hz, 2H), 2.83 (s, 3H), 2.27 (s, 3H).
13C NMR (101 MHz, CDCl3) δ 146.8, 129.7, 126.8, 112.9, 31.3,
20.4. The 1H and 13C NMR spectra are in agreement with those
reported in the literature.17
4.2.12. (5-chloro-2-
(methylamino)phenyl)(phenyl)methanone (3l)
4.2.4. 4-(tert-butyl)-N-methylaniline (3d)
461 mg (68%); yellow solid; 1H NMR (400 MHz, CDCl3) δ 7.63 –
7.58 (m, 2H), 7.57 – 7.52 (m, 1H), 7.51 – 7.43 (m, 3H), 7.37 (dd, J =
9.0, 2.6 Hz, 1H), 6.83 (d, J = 8.9 Hz, 1H), 2.97 (s, 3H). 13C NMR
(101 MHz, CDCl3) δ 198.1, 149.9, 139.4, 134.8, 133.9, 131.3, 129.0,
128.3, 119.6, 118.9, 113.9, 30.3. The 1H and 13C NMR spectra are in
agreement with those reported in the literature.21
1
183 mg (41%); clear oil; H NMR (400 MHz, CDCl3) δ 7.30 –
7.24 (m, 2H), 6.81 – 6.72 (m, 2H), 3.37 (br s, 1H), 2.90 – 2.81 (s,
3H), 1.29 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 146.7, 140.2,
125.9, 112.4, 33.8, 31.5, 31.1. IR (neat, cm-1) 3410 (m), 3054 (w),
2959 (m), 2900 (m), 2868 (m), 2810 (w), 1700 (w), 1617 (m), 1520
(s), 1488 (m), 1459 (m), 1392 (w), 1362 (m), 1348 (m), 1303 (m),
1262 (m), 1193 (m), 1155 (m), 1113 (w), 1058 (w), 931 (w), 819 (s),
4.3. Characterization of reaction intermediates.